Maintenance Therapy with Pembrolizumab after Platinum-Doublet Chemotherapy Leading to Hyperprogression in a Patient with Metastatic Bladder Cancer

by Yangchun Gu, Huiying He, Mopei Wang
Published 2021-01-01

Retrospective Analysis of Risk Factors for Venous Thromboembolism 
in 283 Patients with Lung Cancer during Systemic Therapy

by Yan’e LIU, Yangchun GU, Fumei YI, Baoshan CAO
Published 2019-07-01

Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features

by Yu XIAO, Xiang ZHU, Yangchun GU, Sen CHEN, Li LIANG, Baoshan CAO
Published 2018-03-01

Impact of the Pretreatment or Posttreatment NLR and PLR on the Response of First Line Chemotherapy and the Outcomes in Patients with Advanced Non-small Cell Lung Cancer

by Fumei YI, Yangchun GU, Sen CHEN, Yan’e LIU, Wencheng YIN, Yu ZHANG, Baoshan CAO
Published 2018-06-01

Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observ...

by Hongge Liang, Xia Song, Yuhui Zhang, Shucai Zhang, Fang Li, Jian Fang, Junling Li, Li Liang, Ligong Nie, Kewei Ma, Liangming Zhang, Xiaohong Wang, Junjun Xu, Yanxia Wei, Jinghui Wang, Qi Song, Guangming Tian, Yuxin Mu, Yangchun Gu, Lei Yang, Ping Sun, Wei Zhong, Jing Zhao, Yan Xu, Minjiang Chen, Mengzhao Wang
Published 2019-07-01